Boehringer Ingelheim Roxane Inc is recalling Perindopril Erbumine Tablets, 8mg, specifically the 100-tablet bottles with NDC 0054-0112-25. The recall was issued because testing found out-of-specification results for impurity B, which is the drug's metabolite. This issue affects Lot #160017A, which has an expiration date of April 2013. Read more at govinfonow.com/recall/48450-boehringer-ingelheim-roxane-inc-recalls-perindopril-erbumine-tablets-8mg-100.
“Boehringer Ingelheim Recalls Perindopril Erbumine 8mg Tablets.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48450-boehringer-ingelheim-roxane-inc-recalls-perindopril-erbumine-tablets-8mg-100. Based on FDA recall #D-126-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-126-2013%22&limit=1).
Boehringer Ingelheim Roxane Inc voluntarily recalled Perindopril Erbumine Tablets, 8mg, due to out-of-specification impurity levels, the FDA said on Dec. 12, 2012. The recall affects 3,553 bottles distributed nationwide.
How to tell if you have it
Brand: Boehringer Ingelheim Roxane
Product: Perindopril Erbumine Tablets 8mg
NDC: 0054-0112-25
Lot #: 160017A
Expiration: 04/2013
Quantity: 100 Tablets per Bottle
The hazard
The FDA reported that impurity B, identified as the drug's metabolite, was found in out-of-specification results. The recall is classified as Class III.
Context
GovInfoNow's records show Boehringer Ingelheim Roxane Inc has 12 other recalls on record since 2012-11-05. Other recent recalls of similar products include FUROSEMIDE Tablets USP (2015-09-25), Combivent Respimat (2015-07-24), and Acarbose 50mg Tablets (2015-04-02). Other recent recalls of similar products include Unichem Bisoprolol/Hydrochlorothiazide Tablets (2026-01-21), JB Chemicals Enalapril tablets (2026-04-23), and Breckenridge Duloxetine Capsules (2025-11-24).
How to tell if you have this one
Check your medication bottle for NDC 0054-0112-25 and Lot #160017A. The product is Perindopril Erbumine Tablets, 8mg, sold in bottles of 100 tablets. It was distributed nationwide.
Brand
Boehringer Ingelheim Roxane
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check your medication
Verify if your bottle has NDC 0054-0112-25 and Lot #160017A with an expiration date of April 2013.
Contact your pharmacist
If you have the recalled lot, speak with your pharmacist or healthcare provider about replacing the medication.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 18 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-126-2013 (December 12, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-126-2013 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.